← Back to Screener
Praxis Precision Medicines, Inc. Common Stock (PRAX)
Price$254.00
Value ScoreF
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)21.36%
Price vs S&P 500 (4W)-23.03%
VGM Score35.05
Market Capitalization$7.08B
All Metrics
Book Value / Share (Quarterly)$50.61
P/TBV (Annual)1.99x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-10.13
Price vs S&P 500 (YTD)-21.98%
Net Profit Margin (TTM)-2137.48%
EPS (TTM)$-13.45
10-Day Avg Trading Volume0.58M
EPS Excl Extra (TTM)$-13.45
EPS (Annual)$-13.48
ROI (Annual)-34.54%
Cash / Share (Quarterly)$28.24
ROA (Last FY)-32.33%
EBITD / Share (TTM)$-14.49
ROE (5Y Avg)-120.08%
Operating Margin (TTM)-2340.29%
Cash Flow / Share (Annual)$-9.89
P/B Ratio5.02x
P/B Ratio (Quarterly)6.36x
Net Income / Employee (Annual)$-1,805,200
EV / Revenue (TTM)765.21x
Net Interest Coverage (TTM)-659.00x
ROA (TTM)-53.54%
EPS Incl Extra (Annual)$-13.48
Current Ratio (Annual)10.22x
Quick Ratio (Quarterly)15.66x
3-Month Avg Trading Volume0.44M
52-Week Price Return501.04%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.67
P/S Ratio (Annual)827.92x
Asset Turnover (Annual)0.02x
52-Week High$366.52
EPS Excl Extra (Annual)$-13.48
26-Week Price Return29.29%
Quick Ratio (Annual)10.03x
13-Week Price Return-18.22%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)15.88x
Enterprise Value$6.54B
Asset Turnover (TTM)0.02x
Book Value / Share Growth (5Y)35.94%
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-2137.48%
Cash / Share (Annual)$23.79
3-Month Return Std Dev76.38%
Net Income / Employee (TTM)$-1,805,200
ROE (Last FY)-34.54%
EPS Basic Excl Extra (Annual)$-13.48
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-13.45
ROI (TTM)-58.74%
P/S Ratio (TTM)827.92x
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$1.54
Price vs S&P 500 (52W)476.68%
Year-to-Date Return-13.82%
5-Day Price Return-24.22%
EPS Normalized (Annual)$-13.48
ROA (5Y Avg)-90.67%
Net Profit Margin (Annual)-2137.48%
Month-to-Date Return-27.42%
Cash Flow / Share (TTM)$-1.79
EBITD / Share (Annual)$-14.49
Operating Margin (Annual)-2340.29%
ROI (5Y Avg)-120.08%
EPS Basic Excl Extra (TTM)$-13.45
P/TBV (Quarterly)1.75x
P/B Ratio (Annual)8.39x
Pretax Margin (TTM)-2137.48%
Book Value / Share (Annual)$34.85
Price vs S&P 500 (13W)-26.47%
Beta2.88x
Revenue / Share (TTM)$0.00
ROE (TTM)-58.74%
52-Week Low$37.19
vGradeF
mGradeC
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-3.20est. -3.64
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.13
4.14
4.17
4.17
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PRAXPraxis Precision Medicines, Inc. Common Stock | F | — | C | $254.00 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Praxis Precision Medicines is a clinical-stage biopharmaceutical company developing therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. The company leverages two proprietary platforms, Cerebrum and Solidus, to advance a portfolio of four clinical-stage candidates targeting movement disorders and epilepsy, including Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen.